Search - tctmd.com

Displaying 721 - 740 of 1014

Sort: Relevancy | Date

Presentation TCT 2018

TAVR Outcomes for BAV in Asian Patients

Presenter: Joseph E. Bavaria, Horst Sievert, Jung-Min Ahn

September 22, 2018

Presentation TCT 2018

Device Selection and CT Sizing for TAVR Treatment of BAV

Presenter: Joseph E. Bavaria, Horst Sievert, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

Presenter: Joseph E. Bavaria, Horst Sievert, Hasan Jilaihawi

September 22, 2018

Presentation TCT 2018

A Structural Interventionalist Perspective on BAV Treatment: The Next TAVR Frontier Almost All Patients are TAVR Candidates

Presenter: Joseph E. Bavaria, Horst Sievert, Mathew Williams

September 22, 2018

Presentation TCT 2018

A CT Imaging Perspective on BAV Treatment: Which Patients are Poor Candidates for TAVR

Presenter: Joseph E. Bavaria, Horst Sievert, Jonathon A. Leipsic

September 22, 2018

Presentation TCT 2018

A Surgeons Perspective on BAV Treatment: Why Surgery is Preferred in Many (Most) BAV Patients

Presenter: Joseph E. Bavaria, Horst Sievert

September 22, 2018

Presentation TCT 2018

TCT-88: Optimal Cerebral Protection in Cardiac and Aortic Interventions: Vascular Filters vs. Balloon Occlusion?

Presenter: Jacques Busquet, Virendra I Patel, Michael Zhadkevich

September 21, 2018

Presentation TCT 2018

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Presenter: Jose Armando Mangione

September 21, 2018

Presentation TCT 2018

Debate Pro: TAVR for Moderate-Risk Patients: Ready for Prime Time!

Presenter: Gerardo Nau

September 21, 2018

Presentation TCT 2018

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Presenter: Anibal A. Damonte

September 21, 2018

Presentation TCT 2018

Mitra Clip in the Spotlight: What Should We Proceed After the MITRA-FR Trial?

Presenter: Marco Alcantara

September 21, 2018

Presentation TCT 2018

Mitral Valvular Heart Disease: Diagnosis and Treatment Options 2018

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Ramon Quesada

September 21, 2018

Presentation TCT 2018

Aortic Valvular Heart Disease: Diagnosis and Treatment Options 2018

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Nicola Corvaja

September 21, 2018

Presentation TCT 2018

Atherotomy (Cutting, Scoring, Lithotrispy), Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Robert T. Pyo

September 21, 2018

Presentation TCT 2018

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

September 21, 2018

Presentation TCT 2018

Drug-Eluting Stent Platforms and Outcomes 2018

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Gennaro Sardella

September 21, 2018

Presentation TCT 2018

Cath Lab Room Setup and Basic Equipment (Guiding Catheters, Wires, and Balloons)

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Jasvindar Singh

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

CASE #5 New York City (Columbia)

Presenter: Tamim Nazif

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

CASE #4 Zurich, Switzerland

Presenter: Francesco Maisano

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

CASE #3 Laval, Canada

Presenter: Josep Rodés-Cabau

June 22, 2018

Advertisement

TAVR Outcomes for BAV in Asian Patients

Device Selection and CT Sizing for TAVR Treatment of BAV

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

A Structural Interventionalist Perspective on BAV Treatment: The Next TAVR Frontier Almost All Patients are TAVR Candidates

A CT Imaging Perspective on BAV Treatment: Which Patients are Poor Candidates for TAVR

A Surgeons Perspective on BAV Treatment: Why Surgery is Preferred in Many (Most) BAV Patients

TCT-88: Optimal Cerebral Protection in Cardiac and Aortic Interventions: Vascular Filters vs. Balloon Occlusion?

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Debate Pro: TAVR for Moderate-Risk Patients: Ready for Prime Time!

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Mitra Clip in the Spotlight: What Should We Proceed After the MITRA-FR Trial?

Mitral Valvular Heart Disease: Diagnosis and Treatment Options 2018

Aortic Valvular Heart Disease: Diagnosis and Treatment Options 2018

Atherotomy (Cutting, Scoring, Lithotrispy), Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Drug-Eluting Stent Platforms and Outcomes 2018

Cath Lab Room Setup and Basic Equipment (Guiding Catheters, Wires, and Balloons)

CASE #5 New York City (Columbia)

CASE #4 Zurich, Switzerland

CASE #3 Laval, Canada

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content